I'm not sure our current market cap is really "a song". We currently have no obvious and immediate line to the amount of revenue that would justify it. Unless something changes with the "pandemic" I'm not sure an approved COVID test will do it. And the rest - Influenza/COVID, Sepsis and Battery Tech - are all just potential. Even if some of them are high risk/reward none of it seems to be close to the point of development/proof that would provoke a take over bid.
ADO Price at posting:
15.0¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)